Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference75 articles.
1. ©Les cancers en France, Les Données;Binder-Foucard,2014
2. PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistance;De Bono;Ann Oncol,2016
3. Clinical factors-associated with AR-V7 detection in ARMOR3-SV, a randomized trial of galeterone (Gal) vs. enzalutamide (Enz) in men with AR-V7+ metastatic castration-resistant prostate cancer (mCRPC);Taplin;J Clin Oncol,2017
4. The evolutionary history of lethal metastatic prostate cancer;Gundem;Nature,2015
5. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial;Ledermann;Lancet Oncol,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献